Filter
964
Text search:
drug-resistance
infections
Featured
102
287
Language
Document type
634
129
123
26
23
10
9
6
4
Countries / Regions
54
28
28
27
26
25
24
19
18
18
18
15
15
15
14
14
13
11
11
10
10
10
10
9
9
9
8
7
7
6
6
5
5
5
5
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
359
109
30
21
17
8
7
Toolboxes
191
188
143
23
17
12
9
8
8
7
7
7
6
3
3
3
3
2
2
1
1
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Mapping Report - Ireland.
Sixth edition
2007
This strategic framework marries formerly separate mandates for HIV and TB management in to one, comprehensive collaboration. It provides a structure for how to: strengthen the health care system to respond effectively to both epidemics, reduce the burden of HIV/AIDS in TB patients, and establish a
...
Viral Load Scale-up and Decentralized Testing Experience in Botswana.
This AIDS 2016 presentation highlights how Botswana’s decentralized testing model provides an example of how “taking the services closer to the people, rather than people coming to the services” can increase access, when s
...
Third Edition: Revised October 2012
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Sub-Saharan African Journal of Medicine: Year : 2014 | Volume : 1 | Issue : 1 | Page : 1-14
From policy to practice: how the TB-HIV response is working
“The HIV community must place much more focus on TB co-infection than
it has done to date. TB takes the lives of over 1000 people living with HIV
every day, a number which is absolutely unacceptable. This report highlights that
TB d
...
Global Plan to end TB 2016-2020
First Edition, July 2009
Trainers’ Manual
Key Populations Brief
Accessed November 2017
